Position in ALKS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,875,920
-$1,027,136 QoQ
Shares Held
35,800
-56.4% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#182
of 423 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026KLP KAPITALFORVALTNING AS holds $72,518,901 across 28 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
416,759 | $14,119,794 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
22,680 | $12,288,704 | |
| 3 | ZTS |
Zoetis Inc.
|
170,574 | $12,257,447 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
38,200 | $6,438,228 | |
| 5 | VTRS |
Viatris Inc
|
340,200 | $5,402,376 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
31,223 | $3,463,879 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
113,100 | $2,783,391 | |
| 8 | ALKS |
Alkermes plc.
This page
|
35,800 | $1,875,920 |
All Filings in ALKS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,875,920 | 35,800 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,903,056 | 82,100 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $2,269,178 | 81,100 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $2,412,000 | 80,400 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,122,862 | 74,200 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,265,172 | 68,600 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,044,836 | 71,100 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||